|
Sequence generation
| | | | |
|
adequate reporting
|
23(22%)
|
10(10%)
|
2.44[1.09,5.42]
|
< 0.05
|
|
partial reporting
|
58(54%)
|
25(25%)
| |
< 0.05
|
|
no reporting
|
26(24%)
|
64(75%)
| |
< 0.05
|
|
*adequate + partial reporting
|
81(76%)
|
35(35%)
|
5.70[3.11,10.42]
|
< 0.05
|
|
Allocation concealment
| | | | |
|
adequate reporting
|
6(6%)
|
3(3%)
|
1.90[0.46,7.82]
|
0.89
|
|
partial reporting
|
56(52%)
|
22(22%)
| |
< 0.05
|
|
no reporting
|
45(42%)
|
74(75%)
| |
< 0.05
|
|
*adequate + partial reporting
|
62(58%)
|
25(25%)
|
4.08 [2.25, 7.39]
|
< 0.05
|
|
Blinding
| | | | |
|
adequate reporting
|
24(22%)
|
22(22%)
|
1.01[0.52,1.95]
|
0.97
|
|
partial reporting
|
38(36%)
|
30(30%)
| |
0.43
|
|
no reporting
|
45(42%)
|
47(47%)
| |
0.43
|
|
*adequate + partial reporting
|
62(58%)
|
52(53%)
|
1.25 [0.72, 2.16]
|
0.43
|
|
Sample size calculation
| | | | |
|
adequate reporting
|
28(26%)
|
13(13%)
|
2.34[1.14,4.84]
|
< 0.05
|
|
partial reporting
|
55(52%)
|
34(34%)
| |
< 0.05
|
|
no reporting
|
24(22%)
|
52(53%)
| |
< 0.05
|
|
*adequate + partial reporting
|
83(78%)
|
47(47%)
|
3.83 [2.10, 6.98]
|
< 0.05
|
|
Incomplete outecome data addressed
| | | | |
|
adequate reporting
|
20(19%)
|
12(12%)
|
1.67[0.77,3.62]
|
0.2
|
|
partial reporting
|
32(30%)
|
22(22%)
| |
0.21
|
|
no reporting
|
55(51%)
|
65(66%)
| |
< 0.05
|
|
*adequate + partial reporting
|
52(49%)
|
34(34%)
|
1.81[1.03,3.17]
|
< 0.05
|
|
Intention-to-treat analysis
| | | | |
|
adequate reporting
|
49(46%)
|
30(30%)
|
1.94[1.10,3.45]
|
< 0.05
|
|
partial reporting
|
25(23%)
|
12(12%)
| |
< 0.05
|
|
no reporting
|
33(31%)
|
57(58%)
| |
< 0.05
|
|
*adequate + partial reporting
|
74(69%)
|
42(42%)
|
3.04 [1.72, 5.39]
|
< 0.05
|
|
Free of selective reporting
| | | | |
|
adequate reporting
|
34(32%)
|
20(20%)
|
1.84[0.97,3.48]
|
0.06
|
|
partial reporting
|
23(21%)
|
23(23%)
| |
0.76
|
|
no reporting
|
50(47%)
|
56(57%)
| |
0.16
|
|
*adequate + partial reporting
|
57(53%)
|
43(43%)
|
1.48[0.86,2.57]
|
0.16
|
